FDA approves first two-drug regimen for HIV
On Nov. 21, the U.S. Food and Drug Administration (FDA) approved Juluca, the first treatment regimen containing two drugs to treat certain adults with…
STIs/STDs
HIV patients at greater risk for heart, kidney disease
Patients with HIV who are at high risk for a heart attack or stroke are also at substantially greater risk for chronic kidney disease…
Opening the lines of communication about HPV
When parents resits the HPV (human papillomavirus) vaccine, be prepared to listen and educate. Takeaways Patients and parents may have misconceptions about the purpose…
Protecting communities from the syphilis epidemic from birth through adulthood
There are many colloquialisms for syphilis, the sexually transmitted infection (STI) caused by Treponema pallidum. Whether it’s called “syfy,” “siff,” “pox,” “VD,” “the bug,”…
WHO issues new HIV treatment recommendations
According to a new guideline from the World Health Organization (WHO), anyone infected with HIV should begin antiretroviral treatment as soon after diagnosis as…
New intravaginal ring
Researchers have developed a new intravaginal ring for the sustained 90-day co-delivery of tenofovir and levonorgestrel, an anti-human immunodeficiency virus (HIV) drug and a…
WHO releases guidelines for antiretroviral drugs in HIV
The World Health Organization (WHO) has released “Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection.” Access the guidelines.
Caring for older lesbian, gay, bisexual, and transgender adults
Current discussions on the unique health issues of lesbian, gay, bisexual, and transgender (LGBT) populations have prompted the healthcare professions to reexamine their mission…
Moving the Sharps Safety Agenda Forward: Consensus Statement and Call to Action
Note: This Consensus Statement and Call to Action was drafted by members of the steering committee* for the conference “Tenth Anniversary of the Needlestick…
Choosing wisely: Resources for selecting sharps safety devices
An essential part of a sharps safety program is selecting appropriate devices, such as safety needles. While no one device, feature, or mechanism of…
HAART and its effects on the heart
Many patients with HIV/AIDS are doing well on highly active antiretroviral therapy (HAART). Yet HAART can increase cardiovascular risks by reducing high-density lipoprotein levels,…
Take Note – February 2008
Elizabeth Battaglino Cahill, RN, named executive director of National Women’s Health Resource Center The National Women’s Health Resource Center (NWHRC) has appointed Elizabeth Battaglino…
FDA approves first two-drug regimen for HIV
On Nov. 21, the U.S. Food and Drug Administration (FDA) approved Juluca, the first treatment regimen containing two drugs to treat certain…
HIV patients at greater risk for heart, kidney disease
Patients with HIV who are at high risk for a heart attack or stroke are also at substantially greater risk for chronic…
Opening the lines of communication about HPV
When parents resits the HPV (human papillomavirus) vaccine, be prepared to listen and educate. Takeaways Patients and parents may have misconceptions about…
Protecting communities from the syphilis epidemic from birth through adulthood
There are many colloquialisms for syphilis, the sexually transmitted infection (STI) caused by Treponema pallidum. Whether it’s called “syfy,” “siff,” “pox,” “VD,”…
WHO issues new HIV treatment recommendations
According to a new guideline from the World Health Organization (WHO), anyone infected with HIV should begin antiretroviral treatment as soon after…
New intravaginal ring
Researchers have developed a new intravaginal ring for the sustained 90-day co-delivery of tenofovir and levonorgestrel, an anti-human immunodeficiency virus (HIV) drug…
WHO releases guidelines for antiretroviral drugs in HIV
The World Health Organization (WHO) has released “Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection.” Access…
Caring for older lesbian, gay, bisexual, and transgender adults
Current discussions on the unique health issues of lesbian, gay, bisexual, and transgender (LGBT) populations have prompted the healthcare professions to reexamine…
Moving the Sharps Safety Agenda Forward: Consensus Statement and Call to Action
Note: This Consensus Statement and Call to Action was drafted by members of the steering committee* for the conference “Tenth Anniversary of…
Choosing wisely: Resources for selecting sharps safety devices
An essential part of a sharps safety program is selecting appropriate devices, such as safety needles. While no one device, feature, or…
HAART and its effects on the heart
Many patients with HIV/AIDS are doing well on highly active antiretroviral therapy (HAART). Yet HAART can increase cardiovascular risks by reducing high-density…
Take Note – February 2008
Elizabeth Battaglino Cahill, RN, named executive director of National Women’s Health Resource Center The National Women’s Health Resource Center (NWHRC) has appointed…
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.